Literature DB >> 26013153

Do Surgical Margins Affect Local Recurrence and Survival in Extremity, Nonmetastatic, High-grade Osteosarcoma?

Todd E Bertrand1,2, Alex Cruz3, Odion Binitie4, David Cheong4, G Douglas Letson4.   

Abstract

BACKGROUND: Long-term survival for all patients with osteosarcoma using current aggressive adjuvant chemotherapy and surgical resection is between 60% and 70%. In patients who present with nonmetastatic, high-grade extremity osteosarcoma of bone, limb salvage surgery is favored, when appropriate, over amputation to preserve the limb, because limb salvage may lead to a superior quality of life compared with amputation. However, concern remains that in the attempt to preserve the limb, close or microscopically positive surgical margins may have an adverse effect on event-free survival. QUESTIONS/PURPOSES: (1) Does a positive or close surgical margin increase the likelihood of a local recurrence? (2) Does a positive or close surgical margin adversely affect the development of metastatic disease? (3) What is the relationship of surgical margin on overall survival?
METHODS: With institutional review board approval, we retrospectively evaluated 241 patients treated at our institution between 1999 and 2011. Exclusion criteria included nonextremity locations, metastatic disease at initial presentation, low- or intermediate-grade osteosarcoma, treatment regimens that did not follow National Comprehensive Cancer Network (NCCN) guidelines, incomplete medical records, and any part of treatment performed outside of Moffitt Cancer Center or All Children's Hospital. Fifty-one patients were included in the final analysis, of whom 31 (61%) had followup data at a minimum of 2 years or whose clinical status was known but had died before 2 years of followup. Margin status was defined as (1) microscopically positive; (2) negative ≤ 1 mm; and (3) negative > 1 mm. Margin status, histologic response (tumor percent necrosis), type of osteosarcoma, type of surgery, presence of local recurrence, metastatic disease, and overall survival were recorded for each patient. The mean age was 22 years (range, 12-74 years) and the mean followup was 3 years (range, 0.1-14 years). Margin status was positive in 10% (five of 51), negative ≤ 1 mm 26% (13 of 51), and negative > 1 mm 65% (33 of 51).
RESULTS: Local recurrence was noted to be 14% (seven of 51) at 3.4 years. After controlling for relevant confounding variables, the presence of a positive margin compared with a negative margin > 1 mm was the only independent predictor of local recurrence (hazard ratio [HR], 8.006; 95% confidence interval [CI], 1.314-48.781; p = 0.0241). At a mean of 3.4 years, 29% (15 of 51) of the patients developed metastatic disease with no difference with the numbers available in the probability of developing metastatic disease among the three margin groups (p = 0.614). Overall survival at 3.8 years was 75% (38 of 51). After controlling for relevant confounding variables, we found that patients with positive margins were more likely to die from disease than those with negative margins (HR, 6.26; 95% CI, 1.50-26.14; p = 0.0119); no other independent predictors of survival were identified.
CONCLUSIONS: With the numbers of patients we had, we observed that patients with extremity, nonmetastatic, high-grade osteosarcoma who had positive margins showed a higher probability of local recurrence in comparison to those with negative surgical margins. Given that positive margins appear to be associated with poorer survival in patients with high-grade osteosarcoma of the extremities, surgeons should strive to achieve negative margins, but larger studies are needed to confirm these findings. LEVEL OF EVIDENCE: Level III, therapeutic study.

Entities:  

Mesh:

Year:  2016        PMID: 26013153      PMCID: PMC4746163          DOI: 10.1007/s11999-015-4359-x

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  10 in total

Review 1.  Current strategies of chemotherapy in osteosarcoma.

Authors:  Dorothe Carrle; Stefan S Bielack
Journal:  Int Orthop       Date:  2006-08-03       Impact factor: 3.075

2.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

Authors:  Stefan S Bielack; Beate Kempf-Bielack; Günter Delling; G Ulrich Exner; Silke Flege; Knut Helmke; Rainer Kotz; Mechthild Salzer-Kuntschik; Matthias Werner; Winfried Winkelmann; Andreas Zoubek; Heribert Jürgens; Kurt Winkler
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

3.  Surgical outcomes in osteosarcoma.

Authors:  R J Grimer; A M Taminiau; S R Cannon
Journal:  J Bone Joint Surg Br       Date:  2002-04

4.  Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.

Authors:  Gaetano Bacci; Alessandra Longhi; Michela Versari; Mario Mercuri; Antonio Briccoli; Piero Picci
Journal:  Cancer       Date:  2006-03-01       Impact factor: 6.860

5.  Impact of close surgical margin on local recurrence and survival in osteosarcoma.

Authors:  Xin Li; Vincent M Moretti; Adedayo O Ashana; Richard D Lackman
Journal:  Int Orthop       Date:  2011-03-15       Impact factor: 3.075

6.  Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.

Authors:  Allen M Goorin; Douglas J Schwartzentruber; Meenakshi Devidas; Mark C Gebhardt; Alberto G Ayala; Michael B Harris; Lee J Helman; Holcombe E Grier; Michael P Link
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

7.  The concept of curative margin in surgery for bone and soft tissue sarcoma.

Authors:  Noriyoshi Kawaguchi; Adel Refaat Ahmed; Seiichi Matsumoto; Jun Manabe; Yasushi Matsushita
Journal:  Clin Orthop Relat Res       Date:  2004-02       Impact factor: 4.176

8.  Prognostic factors in the survival of patients diagnosed with primary non-metastatic osteosarcoma with a poor response to neoadjuvant chemotherapy.

Authors:  Rosalvo Zósimo Bispo Júnior; Olavo Pires de Camargo
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

9.  Comparison of the outcome of conventional osteosarcoma at two specialist international orthopaedic oncology centres.

Authors:  Samuel Ford; Adnan Saithna; Robert J Grimer; Piero Picci
Journal:  Sarcoma       Date:  2004

10.  Postoperative nomogram to predict the probability of metastasis in Enneking stage IIB extremity osteosarcoma.

Authors:  Seung Hyun Kim; Kyoo-Ho Shin; Ha Yan Kim; Yong Jin Cho; Jae Kyoung Noh; Jin-Suck Suh; Woo-Ick Yang
Journal:  BMC Cancer       Date:  2014-09-12       Impact factor: 4.430

  10 in total
  36 in total

1.  Are Skin Fiducials Comparable to Bone Fiducials for Registration When Planning Navigation-assisted Musculoskeletal Tumor Resections in a Cadaveric Simulated Tumor Model?

Authors:  Rodolfo Zamora; Stephanie E Punt; Claudia Christman-Skieller; Cengiz Yildirim; John C Shapton; Ernest U Conrad
Journal:  Clin Orthop Relat Res       Date:  2019-12       Impact factor: 4.176

2.  Cadmium in bone cement induces necrosis and decreases the viability of residual osteosarcoma cells: A xenograft study.

Authors:  Nihat Demirhan Demirkıran; Safiye Aktaş; Ayşe Pınar Erçetin Özdemir; Ömer Bekçioğlu; Melek Aydın; Hasan Havitçioğlu
Journal:  Acta Orthop Traumatol Turc       Date:  2020-07       Impact factor: 1.511

Review 3.  Oncologic Procedures Amenable to Fluorescence-guided Surgery.

Authors:  Kiranya E Tipirneni; Jason M Warram; Lindsay S Moore; Andrew C Prince; Esther de Boer; Aditi H Jani; Irene L Wapnir; Joseph C Liao; Michael Bouvet; Nicole K Behnke; Mary T Hawn; George A Poultsides; Alexander L Vahrmeijer; William R Carroll; Kurt R Zinn; Eben Rosenthal
Journal:  Ann Surg       Date:  2017-07       Impact factor: 12.969

4.  MRI Identification of the Osseous Extent of Pediatric Bone Sarcomas.

Authors:  Matthew J Thompson; John C Shapton; Stephanie E Punt; Christopher N Johnson; Ernest U Conrad
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

5.  CORR Insights®: MRI Identification of the Osseous Extent of Pediatric Bone Sarcomas.

Authors:  Richard W Nicholas
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

6.  The effect of preoperative radiotherapy on local control and prognosis in high-grade non-metastatic intramedullary osteosarcoma of the extremities.

Authors:  Bedri Karaismailoglu; Murat Hız; Suat Ulutas; Vedat Burkay Camurdan; Baris Gorgun; Fazilet Oner Dincbas
Journal:  Arch Orthop Trauma Surg       Date:  2020-06-06       Impact factor: 3.067

7.  Is It Appropriate to Treat Sarcoma Metastases With Intramedullary Nailing?

Authors:  Bryan S Moon; Dwayne J Dunbar; Patrick P Lin; Robert L Satcher; Justin E Bird; Valerae O Lewis
Journal:  Clin Orthop Relat Res       Date:  2016-11-01       Impact factor: 4.176

8.  A Novel System for the Surgical Staging of Primary High-grade Osteosarcoma: The Birmingham Classification.

Authors:  Lee M Jeys; Chris J Thorne; Michael Parry; Czar Louie L Gaston; Vaiyapuri P Sumathi; J Robert Grimer
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

9.  Evaluation of factors affecting survival rate in primary bone sarcomas with extremity and pelvis involvement.

Authors:  Ömer Sofulu; Bülent Erol
Journal:  Acta Orthop Traumatol Turc       Date:  2020-05       Impact factor: 1.511

10.  The Significance of a "Close" Margin in Extremity Sarcoma: A Systematic Review.

Authors:  Ike Hasley; Yubo Gao; Amy E Blevins; Benjamin J Miller
Journal:  Iowa Orthop J       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.